EMERPHED

Peak

ephedrine sulfate

NDAINTRAVENOUSSOLUTION
Approved
Apr 2020
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

α- and β-adrenergic receptors and indirectly causes the release of norepinephrine from sympathetic neurons. Pressor effects by direct alpha- and beta-adrenergic receptor activation are mediated by increases in arterial pressures, cardiac output, and peripheral resistance. Indirect adrenergic…

Loss of Exclusivity

LOE Date
May 16, 2040
172 months away
Patent Expiry
May 16, 2040

Patent Records (5)

Patent #ExpiryTypeUse Code
11090278
May 16, 2040
U-3183
11241400
May 16, 2040
U-3183
11464752
May 16, 2040
Product
11478436
May 16, 2040
U-3183
11571398
May 16, 2040
U-3183